Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

665 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II.
Gärtner J, Hauser SL, Bar-Or A, Montalban X, Cohen JA, Cross AH, Deiva K, Ganjgahi H, Häring DA, Li B, Pingili R, Ramanathan K, Su W, Willi R, Kieseier B, Kappos L. Gärtner J, et al. Mult Scler. 2022 Sep;28(10):1562-1575. doi: 10.1177/13524585221078825. Epub 2022 Mar 10. Mult Scler. 2022. PMID: 35266417 Free PMC article. Clinical Trial.
Natalizumab use in pediatric multiple sclerosis.
Huppke P, Stark W, Zürcher C, Huppke B, Brück W, Gärtner J. Huppke P, et al. Among authors: gartner j. Arch Neurol. 2008 Dec;65(12):1655-8. doi: 10.1001/archneur.65.12.1655. Arch Neurol. 2008. PMID: 19064754
Therapy of highly active pediatric multiple sclerosis.
Huppke P, Huppke B, Ellenberger D, Rostasy K, Hummel H, Stark W, Brück W, Gärtner J. Huppke P, et al. Among authors: gartner j. Mult Scler. 2019 Jan;25(1):72-80. doi: 10.1177/1352458517732843. Epub 2017 Sep 21. Mult Scler. 2019. PMID: 28933245
665 results